Secretary Zhang Yuzhuo listened to the introduction, asked about the innovation outcomes, viewed the project demonstration, talked about the industry prospect, and asked in detail for the difficulties and problems that JECHO met in its development, and guided the related district departments for assistance and solution. When hearing that JECHO's first biological medicine treating age-related ocular fundus macular degeneration was to enter the third human body clinical research phase, and several anti-tumor Class I innovative biological drugs was completed for process development and under the engineering scale-up, he was appreciated, and encouraged the company to strictly control the quality in accordance with the international GMP standard, firmly grasp the lifeline of product quality, and become the benchmarking enterprise of the bio-pharmaceutical industry in Binhai New Area. Secretary Zhang Yuzhuo emphasized that, Binhai New Area had a good foundation and outstanding comprehensive advantages to develop the bio-pharmaceutical industry, so we should meet the growing health needs of the masses as the objective, continuously make the bio-pharmaceutical industry bigger and stronger, and promote the scale, industrial and international development of the bio-pharmaceutical industry in Binhai New Area.

 

Dr. Zhu Jianwei said that, JECHO, from the beginning of its establishment, had made planning, design, construction and operational management based on the US, European and other world-class standard, and had reached the international first-class technology and management level in product and process R&D, technological platform construction, quality control, etc., and JECHO would make unremitting efforts for being the world class bio-pharmaceutical enterprise.